Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild‐to‐moderate coronavirus disease 2019 during the Omicron epoch

Transplant Infectious Disease(2022)10.1111/tid.13901Source: DataRank Database

Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild‐to‐moderate coronavirus disease 2019 during the Omicron epoch is a research paper published in Transplant Infectious Disease (2022). On theSindex it has a DataRank of 0. It has been cited 40 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access40 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 3.86)OA: greenTopics (55)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Elena Beam ORCID,John C. O’Horo ORCID,Maria Teresa Seville ORCID,Lisa Brumble ORCID,Ravindra Ganesh ORCID

Live enrichment

PubMed:35848574 PMC:PMC9349935 OpenAlex:https://openalex.org/W4285727819

National Institutes of Health

Grant: UL1TR002377

National Institutes of Health

Grant: 3UL1TR002377-04S5

Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Regan Theiler)

Mayo Clinic

FWCI

3.86

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

greenLicense: Wiley Online Library User Agreement

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9349935

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13901

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1111/tid.13901

journalhttps://doi.org/10.1111/tid.13901

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesRenal Transplantation Outcomes and Treatments03 medical and health sciences0302 clinical medicineAdultAntibodies, Monoclonal, HumanizedAntibodies, NeutralizingCOVID-19 TestingCOVID-19 VaccinesHumansOrgan TransplantationRetrospective StudiesSARS-CoV-2Transplant RecipientsCOVID-19 Drug Treatment

MeSH Terms

SARS-CoV-2COVID-19 VaccinesCOVID-19 TestingCOVID-19 Drug TreatmentAdultHumansRetrospective StudiesOrgan TransplantationAntibodies, NeutralizingAntibodies, Monoclonal, HumanizedTransplant Recipients

Keywords

MedicineEpoch (astronomy)Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Disease2019-20 coronavirus outbreakCoronavirusOrgan transplantationTransplantationInternal medicineIntensive care medicineVirologyAstrophysicsInfectious disease (medical specialty)OutbreakCovid-19Sars-cov-2BebtelovimabAnti-spike Monoclonal AntibodyAdultCOVID-19 VaccinesAntibodies, Monoclonal, HumanizedAntibodies, NeutralizingTransplant RecipientsCOVID-19 Drug TreatmentCOVID-19 TestingHumansRetrospective Studies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being